Logo image of WOK

WORK MEDICAL TECHNOLOGY GROU (WOK) Stock Fundamental Analysis

NASDAQ:WOK - Nasdaq - KYG9767H1092 - Common Stock - Currency: USD

2.31  -0.17 (-6.85%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WOK. WOK was compared to 191 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of WOK while its profitability can be described as average. WOK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year WOK was profitable.
In the past year WOK had a positive cash flow from operations.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

The Return On Assets of WOK (0.37%) is better than 70.53% of its industry peers.
WOK has a better Return On Equity (1.13%) than 71.58% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.47%, WOK is in the better half of the industry, outperforming 69.47% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for WOK is in line with the industry average of 8.09%.
The last Return On Invested Capital (1.47%) for WOK is well below the 3 year average (6.50%), which needs to be investigated, but indicates that WOK had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.37%
ROE 1.13%
ROIC 1.47%
ROA(3y)7.73%
ROA(5y)N/A
ROE(3y)23.04%
ROE(5y)N/A
ROIC(3y)6.5%
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30 40 50

1.3 Margins

WOK has a better Profit Margin (0.83%) than 71.58% of its industry peers.
The Operating Margin of WOK (3.04%) is better than 69.47% of its industry peers.
WOK has a worse Gross Margin (30.54%) than 74.74% of its industry peers.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

WOK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for WOK remains at a similar level compared to 1 year ago.
WOK has a worse debt/assets ratio than last year.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.20 indicates that WOK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of WOK (2.20) is better than 61.58% of its industry peers.
The Debt to FCF ratio of WOK is 5.44, which is a neutral value as it means it would take WOK, 5.44 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of WOK (5.44) is better than 77.89% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that WOK is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.90, WOK is doing worse than 75.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 5.44
Altman-Z 2.2
ROIC/WACC0.21
WACC6.92%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.17 indicates that WOK should not have too much problems paying its short term obligations.
WOK has a worse Current ratio (1.17) than 85.79% of its industry peers.
A Quick Ratio of 0.93 indicates that WOK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, WOK is doing worse than 81.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.93
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WOK have decreased strongly by -87.05% in the last year.
Looking at the last year, WOK shows a very negative growth in Revenue. The Revenue has decreased by -31.18% in the last year.
EPS 1Y (TTM)-87.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.75%
Revenue 1Y (TTM)-31.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-63.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M
WOK Yearly EPS VS EstimatesWOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 231.00, WOK can be considered very expensive at the moment.
Based on the Price/Earnings ratio, WOK is valued a bit cheaper than the industry average as 64.21% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.28, WOK is valued quite expensively.
Industry RankSector Rank
PE 231
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

82.63% of the companies in the same industry are more expensive than WOK, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WOK indicates a rather cheap valuation: WOK is cheaper than 89.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.72
EV/EBITDA 17.16
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WORK MEDICAL TECHNOLOGY GROU

NASDAQ:WOK (1/30/2025, 3:58:31 PM)

2.31

-0.17 (-6.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.70M
AnalystsN/A
Price TargetN/A
Short Float %0.71%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 231
Fwd PE N/A
P/S 2.48
P/FCF 20.72
P/OCF 15.25
P/B 3.41
P/tB 3.8
EV/EBITDA 17.16
EPS(TTM)0.01
EY0.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY4.83%
OCF(TTM)0.15
OCFY6.56%
SpS0.93
BVpS0.68
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 1.13%
ROCE 3.74%
ROIC 1.47%
ROICexc 1.6%
ROICexgc 1.7%
OM 3.04%
PM (TTM) 0.83%
GM 30.54%
FCFM 11.99%
ROA(3y)7.73%
ROA(5y)N/A
ROE(3y)23.04%
ROE(5y)N/A
ROIC(3y)6.5%
ROIC(5y)N/A
ROICexc(3y)6.72%
ROICexc(5y)N/A
ROICexgc(3y)7.14%
ROICexgc(5y)N/A
ROCE(3y)14.39%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 5.44
Debt/EBITDA 4.39
Cap/Depr 36.39%
Cap/Sales 4.3%
Interest Coverage 1.32
Cash Conversion 109.65%
Profit Quality 1451.79%
Current Ratio 1.17
Quick Ratio 0.93
Altman-Z 2.2
F-Score6
WACC6.92%
ROIC/WACC0.21
Cap/Depr(3y)33.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-352.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-63.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y138.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y197.82%
OCF growth 3YN/A
OCF growth 5YN/A